🇺🇸 FDA
Patent

US 11884944

Fusion proteins comprising sulfoglucosamine sulfohydrolase enzymes and methods thereof

granted A61KA61K2039/505A61K38/46

Quick answer

US patent 11884944 (Fusion proteins comprising sulfoglucosamine sulfohydrolase enzymes and methods thereof) held by DENALI THERAPEUTICS INC. expires Mon Jan 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
DENALI THERAPEUTICS INC.
Grant date
Tue Jan 30 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
39
CPC classes
A61K, A61K2039/505, A61K38/46, A61K47/68, A61P